They have demonstrated an increased level of IL-6, IL-8, IL-13, and G-CSF in NMO in comparison to MS, while in MS they revealed enhanced concentrations of IL-9, GM-CSF, macrophage inflammatory protein (MIP)-1β and TNF-α in comparison to NMO patients. The gene discussed is IL13; the disease is myeloid sarcoma.